Halle Capital Management

John Halle, the founder and managing partner, chairs the investment committee and leads day-to-day portfolio construction. He is joined by partners Bret Van Buren and Antony Brindisi, both of whom source and execute transactions across the firm's services and healthcare verticals. The three operate a consensus-driven process typical of a lean, partnership-structured lower-middle-market firm without a separate chief investment officer.

The firm relies on a curated network of regional accounting firms, business brokers, and industry lawyers developed by the founding partners during their tenure at Metalmark Capital and Citigroup. Halle markets its ability to serve as a first institutional capital partner for founder-run businesses, which reduces auction competition from larger private equity firms that prefer institutionally prepared processes. The partners have concentrated on the same service sub-verticals since 2014, giving intermediaries a clear thesis to match against.

Halle invests exclusively in control buyouts. The firm acquires majority positions in founder-owned businesses with $3 million to $15 million in EBITDA and expects to lead subsequent add-on acquisitions to build scale in fragmented industries. It does not take minority growth-equity stakes.

Halle writes initial equity checks between $15 million and $50 million per platform investment, which implies an enterprise-value range of roughly $30 million to $150 million given the firm's use of conservative leverage. The exact check size varies by fund vintage; Fund I was calibrated toward the lower end of that range while Fund II widened capacity slightly (per the firm's official communications).

Halle Capital Management is a private equity firm that manages third-party institutional capital through closed-end commingled funds. It is not a family office. The firm was founded by John Halle, a career private equity investor, and its limited partners include endowments, foundations, and pension funds.

Halle does not invest in technology startups, biotech, real estate, energy exploration, or financial services. The firm's investment memorandum screens out businesses with technology risk, regulatory reimbursement dependency beyond standard healthcare services, or commodity price exposure. The industry concentration remains narrow — business services, healthcare services, and select industrial niches.

Halle generally pursues platform investments as the sole control investor. On larger transactions that approach the upper end of its check-size range, the firm has co-invested with select limited partners. It does not publicize a formal co-investment program.